Tim McCarthy, Chairman of ImmuPharma, talks to Proactive Investor about the first significant investment from two US healthcare specialist funds and ongoing news flow – 15 June 2020

ImmuPharma PLC’s (LON:IMM) Tim McCarthy speaks to Proactive London’s Andrew Scott following the news of new funding through two specialist US healthcare investors. Up to US$6.3mln is being invested into IMM from an issue of unsecured convertible securities and associated options to L1 Capital Global Opportunities Master Fund and Lind Global Macro Fund.